BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang XF, Zhang N, Tsilimigras DI, Weber SM, Poultsides G, Hatzaras I, Fields RC, He J, Scoggins C, Idrees K, Shen P, Maithel SK, Pawlik TM. Surgical Strategies for Bismuth Type I and II Hilar Cholangiocarcinoma: Impact on Long-Term Outcomes. J Gastrointest Surg 2021;25:3084-91. [PMID: 34131864 DOI: 10.1007/s11605-021-05049-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Hu YF, Hu HJ, Lv TR, He ZQ, Dai YS, Li FY. Should more aggressive surgical resection be increasingly considered in the treatment for Bismuth types I and II hilar cholangiocarcinoma? A meta-analysis. Asian J Surg 2022:S1015-9584(22)01751-1. [PMID: 36586821 DOI: 10.1016/j.asjsur.2022.12.043] [Reference Citation Analysis]
2 Lee M, Jung HS, Cho YJ, Yun WG, Han Y, Kim H, Kwon W, Jang JY. Oncological outcome of proximal and middle extrahepatic bile duct cancer according to surgical extent (Is hilar resection oncologically acceptable in proximal and middle extrahepatic bile duct cancer?). HPB (Oxford) 2022;24:2167-74. [PMID: 36253267 DOI: 10.1016/j.hpb.2022.09.009] [Reference Citation Analysis]